ArticleBritish journal of pharmacology2006

The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.

David J Behm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.